Catch up quick: Hims & Hers announced it would sell a compounded version of Novo Nordisks new Wegovy pill for weight loss in February
Cost, more than side effects or age, emerges as one of the clearest predictors of whether someone feels positive about their treatment
Liraglutide, semaglutide and dulaglutide are except for few modifications highly similar to the structure of human GLP-1, while exenatide and lixisenatide are based on exendin-4, a naturally occurring peptide derived from the saliva of the Gila monster, and only share around 50% homology with the human GLP-1 molecule
Without insurance or VA coverage, retail costs for Ozempic can range from $900 to over $1,200 per month out of pocket
These changes can create a gaunt or aged appearance
Here are some examples of GLP-1 agonists: Dulaglutide (marketed as Trulicity) Exenatide (marketed as Byetta and Bydureon) Liraglutide (marketed as Victoza) Lixisenatide (marketed as Adlyxin) Semaglutide (marketed as Ozempic and Rybelsus) Glucagon-like Peptide-1 (GLP-1) Agonists Market Analysis: The Glucagon-like Peptide-1 (GLP-1) Agonists Market size is estimated at USD 11.87 billion in 2023, and is expected to reach USD 12.55 billion by 2028, growing at a CAGR of 1.12% during the forecast period (2023-2028)